“…[7][8][9][10] The decision whether or not to use thrombosis chemoprophylaxis is therefore decided by weighing up the patient's risk for bleeding against the risk of developing VTE. No universal guidelines are available, although the general consensus from various bodies [31,34,38,40] and published articles [6,12,13,21,22,24,25,27,30,33,39] is that use of prophylactic anticoagulation is not advocated in foot and ankle surgery In a previous prospective study, [37] we found that the absolute number of cases of VTE after foot and ankle surgery was unacceptably high (11/130 (8.5%)), although this was not statistically significant owing to the relatively small number of cases. We identified a cohort of patients who were particularly prone to developing VTE after foot and ankle surgery.…”